Physician

Adam J Yu, MD

According to 2025 Medicare claims, Adam Yu, MD (NPI: 1437136520) practices pulmonary disease in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is EAST TEXAS PULMONARY ASSOCIATES OF LONGVIEW, PLLC (NPI: 1407932510; TIN: 752799006) and primary practice location at 75601-5580. Yu is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Yu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 542 traditional Medicare patients, billed 2,582 HCPCS/CPT codes, and received $178,482 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,200 prescription claims across 463 beneficiaries totaling $1,064,308 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 943 claims. Open Payments data shows 18 records totaling $294. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $261,144 to $178,482. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $291,982 to $1,064,308. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $100,049 and ending at $38,771.